U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

U.S. Food and Drug Administration
  1. Home
  2. Drugs
  3. Development & Approval Process | Drugs
  4. CDER Small Business & Industry Assistance (SBIA)
  5. FDA Small Business Regulatory Education for Industry (REdI): Generic Drugs Forum 2016
  1. CDER Small Business & Industry Assistance (SBIA)

FDA Small Business Regulatory Education for Industry (REdI): Generic Drugs Forum 2016

For slides from this event, click heredisclaimer icon

image of CDER SBIA April 2016 REdI

 
This two-day FDA-led forum offered you the opportunity to interact with FDA subject matter experts as we discussed various topics along the dynamic continuum of the generic drug approval process.
 
Keynote Speaker: Kathleen Uhl, M.D. Director, Office of Generic Drugs, CDER, FDA
 
Topics include:
  • Communication with Industry
  • Current Trends in Labeling and Best Practices
  • GDUFA Regulatory Science
 

For more information on

(866)-405-5367 | (301)-796-6707 | CDER Small Business and Industry Assistance CDERSBIA@fda.hhs.gov
 

 

Back to Top